Cargando…
Cell-derived membrane biomimetic nanocarriers for targeted therapy of pulmonary disease
Pulmonary diseases are currently one of the major threats of human health, especially considering the recent COVID-19 pandemic. However, the current treatments are facing the challenges like insufficient local drug concentrations, the fast lung clearance and risks to induce unexpected inflammation....
Autores principales: | Zheng, Xixi, Zhang, Tianyuan, Huang, Ting, Zhou, Yanjun, Gao, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014644/ https://www.ncbi.nlm.nih.gov/pubmed/35447225 http://dx.doi.org/10.1016/j.ijpharm.2022.121757 |
Ejemplares similares
-
Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles
por: Li, Aixue, et al.
Publicado: (2021) -
Biomimetic Nanocarriers for Cancer Target Therapy
por: Guido, Clara, et al.
Publicado: (2020) -
Homotypic Cell Membrane-Cloaked Biomimetic Nanocarrier for the Targeted Chemotherapy of Hepatocellular Carcinoma
por: Liu, Xiaojun, et al.
Publicado: (2019) -
Biomimetic cell-derived nanocarriers in cancer research
por: Soprano, Enrica, et al.
Publicado: (2022) -
Implications of biomimetic nanocarriers in targeted drug delivery
por: Al-Hetty, Hussein Riyadh Abdul Kareem, et al.
Publicado: (2023)